| Doctor At Your Service Pllc | |
|
4242 Medical Dr Suite 6250 San Antonio TX 78229 | |
| (210) 479-3297 | |
| (210) 479-3295 |
| Full Name | Doctor At Your Service Pllc |
|---|---|
| Speciality | Family Medicine |
| Location | 4242 Medical Dr, San Antonio, Texas |
| Authorized Official Name and Position | Antonio Cavazos (PRESIDENT/PHYSICIAN) |
| Authorized Official Contact | 2104793297 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Doctor At Your Service Pllc 4242 Medical Dr Suite 6250 San Antonio TX 78229 Ph: (210) 479-3297 | Doctor At Your Service Pllc 4242 Medical Dr Suite 6250 San Antonio TX 78229 Ph: (210) 479-3297 |
| NPI Number | 1003145483 |
|---|---|
| Provider Enumeration Date | 12/15/2009 |
| Last Update Date | 07/21/2022 |
| Medicare PECOS PAC ID | 1759425143 |
|---|---|
| Medicare Enrollment ID | O20100223000786 |
News Archive
When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.
NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment and management of the neurological complications of diabetes, today reported publication of results from a study conducted at the University of Toronto.
Women could enhance the development of their unborn child's eyesight and brain function by regularly eating fatty fish during pregnancy.
Researchers at Washington University School of Medicine in St. Louis have shown how an aggressive form of multiple myeloma resists chemotherapy.
Life Technologies Corporation and OpGen, Inc., a commercial stage whole genome analysis company, today announced that they have signed a collaboration agreement to develop systems, technologies and applications intended to improve the management and surveillance of microbial outbreaks in the public health and infectious disease markets.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003145483 | NPI | - | NPPES |
| 210627003 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| 207QG0300X | Family Medicine - Geriatric Medicine | (* (Not Available)) | Secondary |
| Provider Name | David G Johnson |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1689609125 PECOS PAC ID: 8820992712 Enrollment ID: I20031121000697 |
News Archive
When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.
NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment and management of the neurological complications of diabetes, today reported publication of results from a study conducted at the University of Toronto.
Women could enhance the development of their unborn child's eyesight and brain function by regularly eating fatty fish during pregnancy.
Researchers at Washington University School of Medicine in St. Louis have shown how an aggressive form of multiple myeloma resists chemotherapy.
Life Technologies Corporation and OpGen, Inc., a commercial stage whole genome analysis company, today announced that they have signed a collaboration agreement to develop systems, technologies and applications intended to improve the management and surveillance of microbial outbreaks in the public health and infectious disease markets.
› Verified 8 days ago
| Provider Name | Luis Alberto Garcia-arecha |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1770588261 PECOS PAC ID: 2062472848 Enrollment ID: I20041015000483 |
News Archive
When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.
NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment and management of the neurological complications of diabetes, today reported publication of results from a study conducted at the University of Toronto.
Women could enhance the development of their unborn child's eyesight and brain function by regularly eating fatty fish during pregnancy.
Researchers at Washington University School of Medicine in St. Louis have shown how an aggressive form of multiple myeloma resists chemotherapy.
Life Technologies Corporation and OpGen, Inc., a commercial stage whole genome analysis company, today announced that they have signed a collaboration agreement to develop systems, technologies and applications intended to improve the management and surveillance of microbial outbreaks in the public health and infectious disease markets.
› Verified 8 days ago
| Provider Name | Hector H Vasquez |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1518075894 PECOS PAC ID: 8729030457 Enrollment ID: I20050210000666 |
News Archive
When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.
NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment and management of the neurological complications of diabetes, today reported publication of results from a study conducted at the University of Toronto.
Women could enhance the development of their unborn child's eyesight and brain function by regularly eating fatty fish during pregnancy.
Researchers at Washington University School of Medicine in St. Louis have shown how an aggressive form of multiple myeloma resists chemotherapy.
Life Technologies Corporation and OpGen, Inc., a commercial stage whole genome analysis company, today announced that they have signed a collaboration agreement to develop systems, technologies and applications intended to improve the management and surveillance of microbial outbreaks in the public health and infectious disease markets.
› Verified 8 days ago
| Provider Name | Candace J Chapin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1568574531 PECOS PAC ID: 2466536792 Enrollment ID: I20080226000470 |
News Archive
When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.
NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment and management of the neurological complications of diabetes, today reported publication of results from a study conducted at the University of Toronto.
Women could enhance the development of their unborn child's eyesight and brain function by regularly eating fatty fish during pregnancy.
Researchers at Washington University School of Medicine in St. Louis have shown how an aggressive form of multiple myeloma resists chemotherapy.
Life Technologies Corporation and OpGen, Inc., a commercial stage whole genome analysis company, today announced that they have signed a collaboration agreement to develop systems, technologies and applications intended to improve the management and surveillance of microbial outbreaks in the public health and infectious disease markets.
› Verified 8 days ago
| Provider Name | Christina M Mkhantar |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1982968970 PECOS PAC ID: 5395992317 Enrollment ID: I20120827000825 |
News Archive
When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.
NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment and management of the neurological complications of diabetes, today reported publication of results from a study conducted at the University of Toronto.
Women could enhance the development of their unborn child's eyesight and brain function by regularly eating fatty fish during pregnancy.
Researchers at Washington University School of Medicine in St. Louis have shown how an aggressive form of multiple myeloma resists chemotherapy.
Life Technologies Corporation and OpGen, Inc., a commercial stage whole genome analysis company, today announced that they have signed a collaboration agreement to develop systems, technologies and applications intended to improve the management and surveillance of microbial outbreaks in the public health and infectious disease markets.
› Verified 8 days ago
| Provider Name | Khan Zafar Shirani |
|---|---|
| Provider Type | Practitioner - Preventive Medicine |
| Provider Identifiers | NPI Number: 1518135904 PECOS PAC ID: 0244470870 Enrollment ID: I20130703000339 |
News Archive
When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.
NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment and management of the neurological complications of diabetes, today reported publication of results from a study conducted at the University of Toronto.
Women could enhance the development of their unborn child's eyesight and brain function by regularly eating fatty fish during pregnancy.
Researchers at Washington University School of Medicine in St. Louis have shown how an aggressive form of multiple myeloma resists chemotherapy.
Life Technologies Corporation and OpGen, Inc., a commercial stage whole genome analysis company, today announced that they have signed a collaboration agreement to develop systems, technologies and applications intended to improve the management and surveillance of microbial outbreaks in the public health and infectious disease markets.
› Verified 8 days ago
| Provider Name | Shibili Sunny |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1669916417 PECOS PAC ID: 8426332917 Enrollment ID: I20170301000263 |
News Archive
When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.
NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment and management of the neurological complications of diabetes, today reported publication of results from a study conducted at the University of Toronto.
Women could enhance the development of their unborn child's eyesight and brain function by regularly eating fatty fish during pregnancy.
Researchers at Washington University School of Medicine in St. Louis have shown how an aggressive form of multiple myeloma resists chemotherapy.
Life Technologies Corporation and OpGen, Inc., a commercial stage whole genome analysis company, today announced that they have signed a collaboration agreement to develop systems, technologies and applications intended to improve the management and surveillance of microbial outbreaks in the public health and infectious disease markets.
› Verified 8 days ago
| Provider Name | Carlos Armando Mota |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1447558416 PECOS PAC ID: 0143506956 Enrollment ID: I20170410002728 |
News Archive
When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.
NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment and management of the neurological complications of diabetes, today reported publication of results from a study conducted at the University of Toronto.
Women could enhance the development of their unborn child's eyesight and brain function by regularly eating fatty fish during pregnancy.
Researchers at Washington University School of Medicine in St. Louis have shown how an aggressive form of multiple myeloma resists chemotherapy.
Life Technologies Corporation and OpGen, Inc., a commercial stage whole genome analysis company, today announced that they have signed a collaboration agreement to develop systems, technologies and applications intended to improve the management and surveillance of microbial outbreaks in the public health and infectious disease markets.
› Verified 8 days ago
| Provider Name | Connie S Wheat |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1497265821 PECOS PAC ID: 0143587063 Enrollment ID: I20171201000939 |
News Archive
When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.
NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment and management of the neurological complications of diabetes, today reported publication of results from a study conducted at the University of Toronto.
Women could enhance the development of their unborn child's eyesight and brain function by regularly eating fatty fish during pregnancy.
Researchers at Washington University School of Medicine in St. Louis have shown how an aggressive form of multiple myeloma resists chemotherapy.
Life Technologies Corporation and OpGen, Inc., a commercial stage whole genome analysis company, today announced that they have signed a collaboration agreement to develop systems, technologies and applications intended to improve the management and surveillance of microbial outbreaks in the public health and infectious disease markets.
› Verified 8 days ago
| Provider Name | Sarah Baker |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1851821789 PECOS PAC ID: 7719241959 Enrollment ID: I20180516000146 |
News Archive
When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.
NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment and management of the neurological complications of diabetes, today reported publication of results from a study conducted at the University of Toronto.
Women could enhance the development of their unborn child's eyesight and brain function by regularly eating fatty fish during pregnancy.
Researchers at Washington University School of Medicine in St. Louis have shown how an aggressive form of multiple myeloma resists chemotherapy.
Life Technologies Corporation and OpGen, Inc., a commercial stage whole genome analysis company, today announced that they have signed a collaboration agreement to develop systems, technologies and applications intended to improve the management and surveillance of microbial outbreaks in the public health and infectious disease markets.
› Verified 8 days ago
| Provider Name | Antonio Cavazos |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1336180439 PECOS PAC ID: 9931112828 Enrollment ID: I20190507002042 |
News Archive
When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.
NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment and management of the neurological complications of diabetes, today reported publication of results from a study conducted at the University of Toronto.
Women could enhance the development of their unborn child's eyesight and brain function by regularly eating fatty fish during pregnancy.
Researchers at Washington University School of Medicine in St. Louis have shown how an aggressive form of multiple myeloma resists chemotherapy.
Life Technologies Corporation and OpGen, Inc., a commercial stage whole genome analysis company, today announced that they have signed a collaboration agreement to develop systems, technologies and applications intended to improve the management and surveillance of microbial outbreaks in the public health and infectious disease markets.
› Verified 8 days ago
| Provider Name | Emily Wilder Weissgarber |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1134784705 PECOS PAC ID: 2062747959 Enrollment ID: I20190715003034 |
News Archive
When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.
NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment and management of the neurological complications of diabetes, today reported publication of results from a study conducted at the University of Toronto.
Women could enhance the development of their unborn child's eyesight and brain function by regularly eating fatty fish during pregnancy.
Researchers at Washington University School of Medicine in St. Louis have shown how an aggressive form of multiple myeloma resists chemotherapy.
Life Technologies Corporation and OpGen, Inc., a commercial stage whole genome analysis company, today announced that they have signed a collaboration agreement to develop systems, technologies and applications intended to improve the management and surveillance of microbial outbreaks in the public health and infectious disease markets.
› Verified 8 days ago
| Provider Name | Sonia F. Rodulfo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1407488752 PECOS PAC ID: 8224465240 Enrollment ID: I20200303001520 |
News Archive
When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.
NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment and management of the neurological complications of diabetes, today reported publication of results from a study conducted at the University of Toronto.
Women could enhance the development of their unborn child's eyesight and brain function by regularly eating fatty fish during pregnancy.
Researchers at Washington University School of Medicine in St. Louis have shown how an aggressive form of multiple myeloma resists chemotherapy.
Life Technologies Corporation and OpGen, Inc., a commercial stage whole genome analysis company, today announced that they have signed a collaboration agreement to develop systems, technologies and applications intended to improve the management and surveillance of microbial outbreaks in the public health and infectious disease markets.
› Verified 8 days ago
| Provider Name | Martha Ann Ruiz |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1548882764 PECOS PAC ID: 7214356047 Enrollment ID: I20200929000959 |
News Archive
When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.
NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment and management of the neurological complications of diabetes, today reported publication of results from a study conducted at the University of Toronto.
Women could enhance the development of their unborn child's eyesight and brain function by regularly eating fatty fish during pregnancy.
Researchers at Washington University School of Medicine in St. Louis have shown how an aggressive form of multiple myeloma resists chemotherapy.
Life Technologies Corporation and OpGen, Inc., a commercial stage whole genome analysis company, today announced that they have signed a collaboration agreement to develop systems, technologies and applications intended to improve the management and surveillance of microbial outbreaks in the public health and infectious disease markets.
› Verified 8 days ago
| Provider Name | Nicole Gutierrez-holubz |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1215529029 PECOS PAC ID: 8224445200 Enrollment ID: I20210319000451 |
News Archive
When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.
NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment and management of the neurological complications of diabetes, today reported publication of results from a study conducted at the University of Toronto.
Women could enhance the development of their unborn child's eyesight and brain function by regularly eating fatty fish during pregnancy.
Researchers at Washington University School of Medicine in St. Louis have shown how an aggressive form of multiple myeloma resists chemotherapy.
Life Technologies Corporation and OpGen, Inc., a commercial stage whole genome analysis company, today announced that they have signed a collaboration agreement to develop systems, technologies and applications intended to improve the management and surveillance of microbial outbreaks in the public health and infectious disease markets.
› Verified 8 days ago
| Provider Name | Amber Casarez |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1669136099 PECOS PAC ID: 1557750775 Enrollment ID: I20220126000110 |
News Archive
When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.
NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment and management of the neurological complications of diabetes, today reported publication of results from a study conducted at the University of Toronto.
Women could enhance the development of their unborn child's eyesight and brain function by regularly eating fatty fish during pregnancy.
Researchers at Washington University School of Medicine in St. Louis have shown how an aggressive form of multiple myeloma resists chemotherapy.
Life Technologies Corporation and OpGen, Inc., a commercial stage whole genome analysis company, today announced that they have signed a collaboration agreement to develop systems, technologies and applications intended to improve the management and surveillance of microbial outbreaks in the public health and infectious disease markets.
› Verified 8 days ago
| Provider Name | Amy Williams |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1023759966 PECOS PAC ID: 1850778044 Enrollment ID: I20220509001466 |
News Archive
When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.
NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment and management of the neurological complications of diabetes, today reported publication of results from a study conducted at the University of Toronto.
Women could enhance the development of their unborn child's eyesight and brain function by regularly eating fatty fish during pregnancy.
Researchers at Washington University School of Medicine in St. Louis have shown how an aggressive form of multiple myeloma resists chemotherapy.
Life Technologies Corporation and OpGen, Inc., a commercial stage whole genome analysis company, today announced that they have signed a collaboration agreement to develop systems, technologies and applications intended to improve the management and surveillance of microbial outbreaks in the public health and infectious disease markets.
› Verified 8 days ago
| Provider Name | Lacey Rea Williams |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1700501004 PECOS PAC ID: 9133597347 Enrollment ID: I20221119000033 |
News Archive
When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.
NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment and management of the neurological complications of diabetes, today reported publication of results from a study conducted at the University of Toronto.
Women could enhance the development of their unborn child's eyesight and brain function by regularly eating fatty fish during pregnancy.
Researchers at Washington University School of Medicine in St. Louis have shown how an aggressive form of multiple myeloma resists chemotherapy.
Life Technologies Corporation and OpGen, Inc., a commercial stage whole genome analysis company, today announced that they have signed a collaboration agreement to develop systems, technologies and applications intended to improve the management and surveillance of microbial outbreaks in the public health and infectious disease markets.
› Verified 8 days ago
| Provider Name | Candis Layton |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1952025959 PECOS PAC ID: 2365805181 Enrollment ID: I20230828001152 |
News Archive
When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.
NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment and management of the neurological complications of diabetes, today reported publication of results from a study conducted at the University of Toronto.
Women could enhance the development of their unborn child's eyesight and brain function by regularly eating fatty fish during pregnancy.
Researchers at Washington University School of Medicine in St. Louis have shown how an aggressive form of multiple myeloma resists chemotherapy.
Life Technologies Corporation and OpGen, Inc., a commercial stage whole genome analysis company, today announced that they have signed a collaboration agreement to develop systems, technologies and applications intended to improve the management and surveillance of microbial outbreaks in the public health and infectious disease markets.
› Verified 8 days ago
News Archive
When treating an infection, physicians may face a choice between using a bactericidal (bacteria-killing) drug, a bacteriostatic (bacteria-inhibiting) drug or a combination of the two.
NeuroMetrix, Inc. (the "Company"), a medical device company focused on the treatment and management of the neurological complications of diabetes, today reported publication of results from a study conducted at the University of Toronto.
Women could enhance the development of their unborn child's eyesight and brain function by regularly eating fatty fish during pregnancy.
Researchers at Washington University School of Medicine in St. Louis have shown how an aggressive form of multiple myeloma resists chemotherapy.
Life Technologies Corporation and OpGen, Inc., a commercial stage whole genome analysis company, today announced that they have signed a collaboration agreement to develop systems, technologies and applications intended to improve the management and surveillance of microbial outbreaks in the public health and infectious disease markets.
› Verified 8 days ago
Texas Bariatric Specialist Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8038 Wurzbach Rd # 650b, San Antonio, TX 78229 Phone: 713-464-7555 Fax: 713-464-0219 | |
Alexis Wiesenthal Md Pa Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 8038 Wurzbach Rd Ste 320, San Antonio, TX 78229 Phone: 210-614-3365 | |
R Family Medical Group, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3110 Nogalitos, Suite 105, San Antonio, TX 78225 Phone: 210-533-0257 Fax: 210-531-9488 | |
Communicare Health Centers Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1200 Brooklyn Ave Ste 300, San Antonio, TX 78212 Phone: 210-225-5930 Fax: 210-476-0246 | |
Insulin Rounds P A Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 12951 Huebner Rd, #780355, San Antonio, TX 78278 Phone: 210-862-5506 | |
Omni Vision Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9218 Potranco Rd, Suite 105, San Antonio, TX 78251 Phone: 832-331-9831 Fax: 210-855-8365 |